Bethany Flynn Schreiber

Bethany Schreiber practices at Medstar Georgetown Medical Center in Washington, District of Columbia.

Bethany Schreiber's NPI, 1477582211, was assigned on July 2, 2006. Bethany Schreiber graduated from Vanderbilt University School of Medicine in 2001. Bethany Schreiber holds District of Columbia license RN965587.

Bethany Schreiber's primary practice is Medstar Georgetown Medical Center, at 3800 Reservoir NW Rd, Washington, DC 20007 in District Of Columbia County. The practice phone is (202) 444-3000.

Bethany Schreiber's primary practice is Medstar Georgetown Medical Center in Washington, District of Columbia. The medical group on file is MedStar Georgetown University Hospital. Dmand AI also links Bethany Schreiber to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bethany Schreiber practices. Vendor and product names are available with a free account.

Neurology is Bethany Schreiber's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Bethany Schreiber is licensed in District of Columbia.

CMS data shows 199 Medicare services from Bethany Schreiber across 5 procedure codes in 2024, for 89 Medicare patients. Medicare paid $18,492 for them. Every service was in an office.

CMS counts 89 Medicare patients who saw Bethany Schreiber in 2024. The largest group is under 65, with 37 patients. 53% of them have high cholesterol, and 52% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Bethany Schreiber's median patient age at 60, with 65% women.

In 2024, Bethany Schreiber wrote 1,024 Medicare Part D claims for 128 patients. 85% of them were for generic drugs. CMS names the drug for 644 of them, across 27 drugs with 11 or more claims each, at $978,846 in total drug cost. In 2023, CMS named 1,074 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Bethany Schreiber for performance year 2024, reported as part of a group. Bethany Schreiber accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 35 general payments to Bethany Schreiber from 7 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $392.

Bethany Schreiber graduated from Vanderbilt University School of Medicine in 2001.